Browsing by Author "Heuvel, M. van den"

Now showing items 1-50 of 51

Programmed Cell Death-1/ Ligand-1 PET Imaging A Novel Tool to Optimize Immunotherapy?
Verhoeff, S.R. ; Heuvel, M. van den ; Herpen, C.M.L. van ; Piet, B.; Aarntzen, E.H.J.G. ; Heskamp, S.
2020, Article / Letter to editor (Pet Clinics, vol. 15, iss. 1, (2020), pp. 35-43)
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human Plasma
Hombergh, E.C.A. van den ; Rouw, N. de ; Heuvel, M. van den ; Croes, S.; Burger, D.M. ; Derijks, J.; Erp, N.P. van ; Heine, R. ter
2020, Article / Letter to editor (Therapeutic Drug Monitoring, vol. 42, iss. 1, (2020), pp. 146-150)
Local and regional treatment response by (18)FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLC
Diessen, Judi N.A. van; Fontaine, Matthew La; Heuvel, M. van den ; Werkhoven, E. van; Walraven, Iris; Vogel, W.V.; Belderbos, J.S.; Sonke, J.J.
2020, Article / Letter to editor (Radiotherapy and Oncology, vol. 143, (2020), pp. 30-36)
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions
Rouw, N. de ; Visser, S.; Koolen, S.L.; Aerts, J.; Heuvel, M. van den ; Derijks, H.J.; Burger, D.M. ; Heine, R. ter
2020, Article / Letter to editor (Cancer Chemotherapy and Pharmacology, vol. 85, iss. 1, (2020), pp. 231-235)
Evaluation of a Hybrid Capture-Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and Processes
Kroeze, L.; Voer, R.M. de ; Kamping, E.J. ; Rhein, D.T. von ; Jansen, E. ; Hermsen, Mandy J.W.; Heuvel, M. van den ; Grunberg, K.; Ligtenberg, M.J.L.
2020, Article / Letter to editor (Journal of Molecular Diagnostics, vol. 22, iss. 6, (2020), pp. 757-769)
Comparability of PD-L1 immunohistochemistry assays for non-small-cell lung cancer: a systematic review.
Koomen, B.M.; Badrising-Soenessardien, S.K.; Heuvel, M. van den ; Willems, S.M.
2020, Article / Letter to editor (Histopathology, vol. 76, iss. 6, (2020), pp. 793-802)
Cumulative pemetrexed dose increases the risk of nephrotoxicity
Rouw, H.J.A. de ; Boosman, R.J.; Bruinhorst, H. van de; Biesma, B.; Heuvel, M. van den ; Burger, D.M. ; Hilbrands, L.B. ; Heine, R. ter ; Derijks, H.J.
2020, Article / Letter to editor (Lung Cancer, vol. 146, (2020), pp. 30-35)
Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma
Theelen, W.S.M.E.; Krijgsman, O.; Monkhorst, K.; Kuilman, T.; Peters, D.D.G.C.; Cornelissen, S.; Heuvel, M. van den ; Schulze, K.
2020, Article / Letter to editor (Journal of Translational Medicine, vol. 18, iss. 1, (2020), article 271)
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease
Gommans, D.H.F. ; Nas, J. ; Pinto-Sietsma, S.J.; Koop, Y. ; Konst, R.E. ; Mensink, F.B. ; Aarts, G.W.A. ; Konijnenberg, L.S.F. ; Cortenbach, K.R. ; Verhaert, D.V.M. ; Thannhauser, J. ; Mol, J.H.Q. ; Rooijakkers, M.J.P. ; Vos, J.L. ; Rumund, A. van ; Vart, P. ; Hassing, R.J.; Cornel, J.H. ; Jager, C.P.C. de; Heuvel, M. van den ; Hoeven, J.G. van der ; Royen, N. van ; Kimmenade, R.R.J. van et al. sine al.
2020, Article / Letter to editor (American Heart Journal, vol. 226, (2020), pp. 60-68)
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
Haan, R. den; Werkhoven, E. van; Heuvel, M. van den ; Peulen, H.M.U.; Sonke, G.S.; Elkhuizen, P.; Brekel, M.W. van den; Tesselaar, M.E.; Vens, C.; Schellens, J.H.; Triest, B. van; Verheij, M. et al. sine al.
2019, Article / Letter to editor (BMC Cancer, vol. 19, (2019), article 901)
Pre-hydration in cisplatin-based CCRT: Effects on tumour concentrations and treatment outcome
Aalbersberg, E.A.; Rossi, M.M.; Veen, L.J. de Wit-van der; Walraven, I.; Heuvel, M. van den ; Sonke, J.J.; Belderbos, J.S.; Vogel, W.V.
2019, Article / Letter to editor (Radiotherapy and Oncology, vol. 134, (2019), pp. 30-36)
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib
Thunnissen, E.; Lissenberg-Witte, B.I.; Heuvel, M. van den ; Monkhorst, K.; Skov, B.G.; Sorensen, J.B.; Drift, M.A. van der ; Looijen-Salamon, M.G. ; Wolf, J.; Pauwels, P.; Smit, E. et al. sine al.
2019, Article / Letter to editor (Lung Cancer, vol. 138, (2019), pp. 13-18)
Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath
Vries, R. de; Muller, M; Noort, V. van den; Theelen, W.; Schouten, R.D.; Hummelink, K.; Muller, S.H.; Wolf-Lansdorf, M.; Dagelet, J.W.F.; Monkhorst, K.; Zee, A.H. Maitland-van de; Baas, P.; Sterk, P.J.; Heuvel, M. van den et al. sine al.
2019, Article / Letter to editor (Annals of Oncology, vol. 30, iss. 10, (2019), pp. 1660-1666)
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes
Meijer, T.W.H. ; Looijen-Salamon, M.G. ; Lok, J. ; Heuvel, M. van den ; Tops, B.B.; Kaanders, J.H.A.M. ; Span, P.N. ; Bussink, J.
2019, Article / Letter to editor (Thoracic Cancer, vol. 10, iss. 12, (2019), pp. 2289-2299)
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Mazieres, J.; Drilon, A.; Lusque, A.; Mhanna, L.; Cortot, A.B.; Mezquita, L.; Thai, A.A.; Mascaux, C.; Couraud, S.; Veillon, R.; Heuvel, M. van den ; Neal, J.; Peled, N.; Fruh, M.; Ng, T.L.; Gounant, V.; Popat, S.; Diebold, J.; Sabari, J.; Zhu, V.W.; Rothschild, S.I.; Bironzo, P.; Martinez-Marti, A.; Curioni-Fontecedro, A.; Rosell, R.; Lattuca-Truc, M.; Wiesweg, M.; Besse, B. de; Solomon, B.; Barlesi, F.; Schouten, R.D.; Wakelee, H.; Camidge, D.R.; Zalcman, G.; Novello, S.; Ou, S.I.; Milia, J.; Gautschi, O. et al. sine al.
2019, Article / Letter to editor (Annals of Oncology, vol. 30, iss. 8, (2019), pp. 1321-1328)
Rapid regression of neurological symptoms in patients with metastasised ALK+ lung cancer who are treated with lorlatinib: a report of two cases
Gafer, H.; Waard, Q. de; Compter, A.; Heuvel, M. van den
2019, Article / Letter to editor (BMJ Case Reports, vol. 12, iss. 7, (2019), article e227299)
Risk Assessment After a Severe Hospital-Acquired Infection Associated With Carbapenemase-Producing Pseudomonas aeruginosa
Hopman, J. ; Meijer, C.; Kenters, N.; Coolen, J.P.M. ; Ghamati, M. ; Mehtar, S.; Crevel, R. van ; Morshuis, W.J. ; Verhagen, A.F.T.M. ; Heuvel, M. van den ; Voss, A. ; Wertheim, H.F.L. et al. sine al.
2019, Article / Letter to editor (JAMA Network Open, vol. 2, iss. 2, (2019), pp. e187665)
Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity
Broek, D. van den; Hiltermann, T.J.N.; Biesma, B.; Dinjens, W.N.; Hart, N.A. t; Hinrichs, J.W.; Leers, M.P.G.; Monkhorst, K.; Oosterhout, M. van; Scharnhorst, V.; Schuuring, E.; Speel, E.M.; Heuvel, M. van den ; Schaik, R.H. van; Thusen, J. von der; Willems, S.M.; Visser, L de; Ligtenberg, M.J.L. et al. sine al.
2019, Article / Letter to editor (Frontiers in Oncology, vol. 9, (2019), article 1521)
Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile
Groot, Rosa de; Loenen, M.M. Van; Guislain, A.; Nicolet, B.P.; Heeren, J.J. Freen-Van; Verhagen, O.; Heuvel, M. van den ; Jong, Jeroen de; Burger, P.; Schoot, C.E. van der; Spaapen, R.M.; Amsen, D.; Haanen, J.; Monkhorst, K.; Hartemink, K.J.; Wolkers, M.C. et al. sine al.
2019, Article / Letter to editor (Oncoimmunology, vol. 8, iss. 11, (2019), pp. e1648170)
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions
Hummelink, K.; Muller, M; Linders, T.C.; Noort, V. van den; Nederlof, P.M.; Baas, P.; Burgers, S.; Smit, E.F.; Meijer, G.A.; Heuvel, M. van den ; Broek, D. van den; Monkhorst, K. et al. sine al.
2019, Article / Letter to editor (ERJ Open Research, vol. 5, iss. 1, (2019), article 00016-2019)
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFN gamma signaling in non-small cell lung cancer
Theelen, Willemijn S.M.E.; Kuilman, Thomas; Schulze, Katja; Zou, Wei; Krijgsman, Oscar; Peters, Dennis D.G.C.; Heuvel, M. van den ; Kowanetz, Marcin
2019, Article / Letter to editor (PLoS One, vol. 14, iss. 5, (2019), article e0216864)
Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials
Haan, R. den; Pluim, D.; Triest, B. van; Heuvel, M. van den ; Peulen, H.; Berlo, D. van; George, J.; Verheij, M.; Schellens, J.H.; Vens, C.
2018, Article / Letter to editor (Radiotherapy and Oncology, vol. 126, iss. 3, (2018), pp. 443-449)
[National variation in molecular diagnostics in metastatic lung cancer].
Kuijpers, C.C.; Heuvel, M. van den ; Overbeek, L.I.H; Slooten, H.J. van; Lindert, A.S.R. van; Damhuis, R.A.; Willems, S.M.
2018, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 162, (2018), article D1607)
FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome.
Schrijver, W.; Schuurman, K.; Rossum, A. van; Droog, M.; Jeronimo, C.; Salta, S.; Henrique, R.; Wesseling, J.; Moelans, C.; Linn, S.C.; Heuvel, M. van den ; Diest, P. van; Zwart, W. et al. sine al.
2018, Article / Letter to editor (Molecular Oncology, vol. 12, iss. 11, (2018), pp. 1884-1894)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
Paz-Ares, L.; Luft, A.; Vicente, D.; Tafreshi, A.; Gumus, M.; Mazieres, J.; Hermes, B.; Cay Senler, F.; Csoszi, T.; Fulop, A.; Rodriguez-Cid, J.; Wilson, J.; Sugawara, S.; Kato, T.; Lee, K.H.; Cheng, Y.; Novello, S.; Halmos, B.; Li, X; Lubiniecki, G.M.; Heuvel, M. van den ; Piperdi, B.; Kowalski, D.M. et al. sine al.
2018, Article / Letter to editor (The New England Journal of Medicine, vol. 379, iss. 21, (2018), pp. 2040-2051)
Real life experience with nivolumab for the treatment of non-small cell lung carcinoma: Data from the expanded access program and routine clinical care in a tertiary cancer centre-The Netherlands Cancer Institute
Schouten, R.D.; Muller, M. ; Gooijer, C.J. de; Baas, P.; Heuvel, M. van den
2018, Article / Letter to editor (Lung Cancer, vol. 126, (2018), pp. 210-216)
Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot
Moritz, R.; Muller, M. ; Korse, C.M.; Broek, D. van den; Baas, P.; Noort, V. van den; Heuvel, M. van den ; Rossum, H.H. van
2018, Article / Letter to editor (Clinica Chimica Acta, vol. 487, (2018), pp. 6-14)
Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer
Kuijpers, C.; Hendriks, L.E.; Derks, J.L.; Dingemans, A.C.; Lindert, A.S.R. van; Heuvel, M. van den ; Damhuis, R.A.; Willems, S.M.
2018, Article / Letter to editor (Lung Cancer, vol. 121, (2018), pp. 76-81)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Antonia, S.J.; Villegas, A.; Daniel, D.; Vicente, D.; Murakami, S.; Hui, R.; Kurata, T.; Chiappori, A.; Lee, K.H.; Wit, M. de; Cho, B.C.; Bourhaba, M.; Quantin, X.; Tokito, T.; Mekhail, T.; Planchard, D.; Kim, Y.C.; Karapetis, C.S.; Hiret, S.; Ostoros, G.; Kubota, K.; Gray, J.E.; Paz-Ares, L.; Castro Carpeno, J. de; Faivre-Finn, C.; Reck, M.; Vansteenkiste, J.; Spigel, D.R.; Wadsworth, C.; Melillo, G.; Taboada, M.; Heuvel, M. van den ; Dennis, P.A.; Ozguroglu, M. et al. sine al.
2018, Article / Letter to editor (The New England Journal of Medicine, vol. 379, iss. 24, (2018), pp. 2342-2350)
Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management.
Geukes Foppen, M.H.; Rozeman, E.A.; Wilpe, S. van ; Postma, C.; Snaebjornsson, P.; Thienen, J.V. van; Leerdam, M.E. van; Heuvel, M. van den ; Blank, C.U.; Dieren, J. van; Haanen, J.B.A.G. et al. sine al.
2018, Article / Letter to editor (Esmo Open, vol. 3, iss. 1, (2018), article e000278)
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial.
Janne, P.A.; Heuvel, M. van den ; Barlesi, F.; Cobo, M.; Mazieres, J.; Crino, L.; Orlov, S.; Blackhall, F.; Wolf, J.; Garrido, P.; Poltoratskiy, A.; Mariani, G.; Ghiorghiu, D.; Kilgour, E.; Smith, P.; Kohlmann, A.; Carlile, D.J.; Lawrence, D.; Bowen, K.; Vansteenkiste, J. et al. sine al.
2017, Article / Letter to editor (Jama : Journal of the American Medical Association, vol. 317, iss. 18, (2017), pp. 1844-1853)
A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
Boshuizen, R.C.; Vander Noort, V.; Burgers, J.A.; Herder, G.J.M.; Hashemi, S.M.; Hiltermann, T.J.N.; Kunst, P.W.; Stigt, J.A.; Heuvel, M. van den
2017, Article / Letter to editor (Lung Cancer, vol. 108, (2017), pp. 9-14)
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
Best, M.G.; Sol, N.; Veld, S.; Vancura, A.; Muller, M. ; Niemeijer, A.N.; Fejes, A.V.; Tjon Kon Fat, L.A.; Huis in 't Veld, A.E.; Leurs, C.; Large, T.Y. Le; Meijer, L.L.; Kooi, I.E.; Rustenburg, F.; Schellen, P.; Verschueren, H.; Post, E.; Wedekind, L.E.; Bracht, J.; Esenkbrink, M.; Wils, L.; Favaro, F.; Schoonhoven, J.D.; Tannous, J.; Meijers-Heijboer, H.; Kazemier, G.; Giovannetti, E.; Reijneveld, J.C.; Idema, S.; Killestein, J.; Heger, M.; Jager, S.C. de; Urbanus, R.T.; Hoefer, I.E.; Pasterkamp, G.; Mannhalter, C.; Gomez-Arroyo, J.; Bogaard, H.J.; Noske, D.P.; Vandertop, W.P.; Broek, D. van den; Ylstra, B.; Nilsson, R.J.; Wesseling, P. ; Karachaliou, N.; Rosell, R.; Lee-Lewandrowski, E.; Lewandrowski, K.B.; Tannous, B.A.; Langen, A.J. de; Smit, E.F.; Heuvel, M. van den ; Wurdinger, T. et al. sine al.
2017, Article / Letter to editor (Cancer Cell, vol. 32, iss. 2, (2017), pp. 238-252.e9)
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)
Peters, S.; Gettinger, S.; Johnson, M.L.; Janne, P.A.; Garassino, M.C.; Christoph, D.; Toh, C.K.; Rizvi, N.A.; Chaft, J.E.; Costa, E.; Patel, J.D.; Chow, L.Q.M.; Koczywas, M.; Ho, C.; Fruh, M.; Heuvel, M. van den ; Rothenstein, J.; Reck, M.; Paz-Ares, L.; Shepherd, F.A.; Kurata, T.; Li, Z.; Qiu, J.; Kowanetz, M.; Mocci, S.; Shankar, G.; Sandler, A.; Felip, E. et al. sine al.
2017, Article / Letter to editor (Journal of Clinical Oncology, vol. 35, iss. 24, (2017), pp. 2781-2789)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Antonia, S.J.; Villegas, A.; Daniel, D.; Vicente, D.; Murakami, S.; Hui, R.; Yokoi, T.; Chiappori, A.; Lee, K.H.; Wit, M. de; Cho, B.C.; Bourhaba, M.; Quantin, X.; Tokito, T.; Mekhail, T.; Planchard, D.; Kim, Y.C.; Karapetis, C.S.; Hiret, S.; Ostoros, G.; Kubota, K.; Gray, J.E.; Paz-Ares, L.; Castro Carpeno, J. de; Wadsworth, C.; Melillo, G.; Jiang, H.; Huang, Y.; Dennis, P.A.; Ozguroglu, M.; Heuvel, M. van den ; et al. et al. sine al.
2017, Article / Letter to editor (The New England Journal of Medicine, vol. 377, iss. 20, (2017), pp. 1919-1929)
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
Carbone, D.P.; Reck, M.; Paz-Ares, L.; Creelan, B.; Horn, L.; Steins, M.; Felip, E.; Heuvel, M. van den ; Ciuleanu, T.E.; Badin, F.; Ready, N.; Hiltermann, T.J.N.; Nair, S.; Juergens, R.; Peters, S.; Minenza, E.; Wrangle, J.M.; Rodriguez-Abreu, D.; Borghaei, H.; umenschein GR, J.r. Bl; Villaruz, L.C.; Havel, L.; Krejci, J.; rral Jaime, J. Co; Chang, H.; Geese, W.J.; Bhagavatheeswaran, P.; Chen, A.C.; Socinski, M.A. et al. sine al.
2017, Article / Letter to editor (The New England Journal of Medicine, vol. 376, iss. 25, (2017), pp. 2415-2426)
A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma.
Wang, L.; Sustic, T.; Leite de Oliveira, R.; Lieftink, C.; Halonen, P.; Ven, M. van de; Beijersbergen, R.L.; Heuvel, M. van den ; Bernards, R.; Heijden, M.S. van der
2017, Article / Letter to editor (European Urology, vol. 71, iss. 6, (2017), pp. 858-862)
Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.
Bins, S.; Cirkel, G.A.; Gadellaa-van Hooijdonk, C.G.M.; Weeber, F.; Numan, I.J.; Bruggink, A.H.; Diest, P.J. van; Willems, S.M.; Veldhuis, W.B.; Heuvel, M. van den ; Knegt, R.J. de; Koudijs, M.J.; Werkhoven, E. van; Mathijssen, R.H.; Cuppen, E.; Sleijfer, S.; Schellens, J.H.; Voest, E.E.; Langenberg, M.H.; Jonge, M.J. de; Steeghs, N.; Lolkema, M.P. et al. sine al.
2017, Article / Letter to editor (Oncologist, vol. 22, iss. 1, (2017), pp. 33-40)
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
Gautschi, O.; Milia, J.; Filleron, T.; Wolf, J.; Carbone, D.P.; Owen, D.; Camidge, R.; Narayanan, V.; Doebele, R.C.; Besse, B. de; Remon-Masip, J.; Janne, P.A.; Awad, M.M.; Peled, N.; Byoung, C.C.; Karp, D.D.; Heuvel, M. van den ; Wakelee, H.A.; Neal, J.W.; Mok, T.S.K.; Yang, J.C.H.; Ou, S.I.; Pall, G.; Froesch, P.; Zalcman, G.; Gandara, D.R.; Riess, J.W.; Velcheti, V.; Zeidler, K.; Diebold, J.; Fruh, M.; Michels, S.; Monnet, I.; Popat, S.; Rosell, R.; Karachaliou, N.; Rothschild, S.I.; Shih, J.Y.; Warth, A.; Muley, T.; Cabillic, F.; Mazieres, J.; Drilon, A. et al. sine al.
2017, Article / Letter to editor (Journal of Clinical Oncology, vol. 35, iss. 13, (2017), pp. 1403-1410)
Commentary on the MID3 Good Practices Paper
Manolis, E.; Brogren, J.; Cole, S.; Hay, J.L.; Nordmark, A.; Karlsson, K.E.; Lentz, F.; Benda, N.; Wangorsch, G.; Pons, G.; Zhao, W.; Gigante, V.; Serone, F.; Standing, J.F.; Dokoumetzidis, A.; Vakkilainen, J.; Heuvel, M. van den ; Sanjuan, V. Mangas; Taminiau, J.; Kerwash, E.; Khan, D.; Musuamba, F.T.; Rusten, I. Skottheim et al. sine al.
2017, Article / Letter to editor (Cpt Pharmacometrics and Systems Pharmacology, vol. 6, iss. 7, (2017), pp. 416-417)
Polymerization-induced color changes of polydiacetylene-containing liposomes and peptide amphiphile fibers
Ramakers, B.E.I.; Heuvel, M. van den ; Spithas, N.T.I.; Brinkhuis, R.P.; Hest, J.C.M. van ; Lowik, D.W.P.M.
2012, Article / Letter to editor (Langmuir, vol. 28, iss. 4, (2012), pp. 2049-2055)
Structure and properties of polydiacetylene-containing peptide amphiphile fibres
Heuvel, M. van den
2011, Dissertation
Mechanical and thermal stabilities of peptide amphiphile fibres
Heuvel, M. van den ; Baptist, H.; Venema, P.; Linden, EE van der; Lowik, D.W.P.M. ; Hest, J.C.M. van
2011, Article / Letter to editor (Soft Matter, vol. 7, iss. 20, (2011), pp. 9737-9743)
Patterned peptide-amphiphile based polydiacetylenes: Creating nanofibers of defined dimensions
Lowik, D.W.P.M. ; Heuvel, M. van den ; Hest, J.C.M. van
2011, Article / Letter to editor (Biopolymers, vol. 96, iss. 4, (2011), pp. 451-452)
Stimulus responsive peptide based materials
Lowik, D.W.P.M. ; Leunissen, E.H.P.; Heuvel, M. van den ; Hansen, M.B. ; Hest, J.C.M. van
2010, Article / Letter to editor (Chemical Society Reviews, vol. 39, iss. 9, (2010), pp. 3394-3412)
Peptide-amphiphile based polydiacetylenes: making nanofibers of defined dimensions
Lowik, D.W.P.M. ; Heuvel, M. van den ; Hest, J.C.M. van
2010, Article / Letter to editor (Journal of Peptide Science, vol. 16, (2010), pp. 36-37)
Effect of the Diacetylene Position on the Chromatic Properties of Polydiacetylenes from Self-Assembled Peptide Amphiphiles
Heuvel, M. van den ; Lowik, D.W.P.M. ; Hest, J.C.M. van
2010, Article / Letter to editor (Biomacromolecules, vol. 11, iss. 6, (2010), pp. 1676-1683)
Delivery of DNA and siRNA by novel gemini-like amphiphilic peptides
Damen, M. ; Aarbiou, J.; Dongen, S.F.M. van ; Buijs-Offerman, R.M.; Spijkers, P.P.; Heuvel, M. van den ; Kvashnina, K.; Nolte, R.J.M. ; Scholte, B.J.; Feiters, M.C.
2010, Article / Letter to editor (Journal of Controlled Release, vol. 145, iss. 1, (2010), pp. 33-39)
Patterns of Diacetylene-Containing Peptide Amphiphiles Using Polarization Holography
Heuvel, M. van den ; Prenen, A.M.; Gielen, J.C. ; Christianen, P.C.M. ; Broer, D.J.; Lowik, D.W.P.M. ; Hest, J.C.M. van
2009, Article / Letter to editor (Journal of the American Chemical Society, vol. 131, iss. 41, (2009), pp. 15014-15017)
Peptide Amphiphile Ppolymer Nanofibers of Defined Dimensions
Heuvel, M. van den ; Hest, J.C.M. van ; Lowik, D.W.P.M.
2009, Article / Letter to editor (Biopolymers, vol. 92, iss. 4, (2009), pp. 340)

Now showing items 1-50 of 51

Radboud Repository

Browsing by Author "Heuvel, M. van den"

Search Repository

Browse

All of Repository